COVID-19 Telemedicine 'Äì an infectious disease management tool for governments all over Europe that will reduce casualties from COVID-19 as well as prepare governments for the next wave of epidemics.
- Funded by European Commission
- Total publications:0 publications
Grant number: 962678
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$2,872,684.04Funder
European CommissionPrincipal Investigator
Cooley DeborahResearch Location
DenmarkLead Research Institution
Levvel Health ApSResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
Digital HealthStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
COVID-19 telemedicine will provide the solution for remote monitoring and telemedicine for COVID-19 patients. The platform is developed for COPD and heart patients over the past 6 years and with this project we will be able to innovate home-monitoring, scale it up massively and collect big data to analyse the development and patterns through AI. The result will be a fully rolled-out infectious disease management tool for governments all over Europe that will reduce casualties from COVID-19 as well as prepare governments for the next wave of epidemics. The company is formed to meet the need for a solution for the COVID-19 outbreak. This innovation forms the foundation of the company and the team is put together because they are the right people to execute the vision of actually making a major impact against the novel corona virus. They are experts in scaleup, product development, fundraising, marketing and communication. The support and interest in the solution is massive even at this TRL 8 stage of the first two parts of the full innovation that is threesome. This innovation project will elevate the solution to save lives!